Articles dans des revues avec comité de lecture (29)
  1. 1. Grosbois, J., Bisteau, X., Imbault, V., Conrard, L., Condorelli, M., Findikli, N., Lybaert, P., & Demeestere, I. (2025). Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage. Human reproduction. doi:10.1093/humrep/deaf203
  2. 2. Ramos, A. R., Bregni, G., Gillet, N., Ando, K., Bodart, C., Vercauteren Drubbel, A., Descampe, L., Moresi, F., Bisteau, X., Verheye, Q., Pirard, S., Erneux, C., & Beck, B. (2025). SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. Molecular cancer.
  3. 3. Kosa, A.-C., López Gutiérrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet-Depauw, A., Pieters, K., Van Morckhoven, D., Imbault, V., Dubois, C., Bisteau, X., Stamatopoulos, B., Igoillo Esteve, M., Brion, J. P., & Leroy, K. (2025). Differential effects of age and sex on tau pathology propagation in the htau mouse model: a neuropathological and proteomic study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e70784. doi:doi.org/10.1002/alz.70784
  4. 4. Bande, M., Delporte, C., SAKIRA, A. K., Bourez, A., Imbault, V., Bisteau, X., Sombié, C., Some, T. I., & Van Antwerpen, P. (2025). Development of An Analytical Model for Assessing the Adsorptive Properties of Traditional Medicinal Formulations from Burkina Faso in Relation to Snake Venom Proteins. Toxicon, 108470. doi:10.1016/j.toxicon.2025.108470
  5. 5. Kaafarani, A., Darche-Gabinaud, R., Bisteau, X., Imbault, V., Wittamer, V., Parmentier, M., & Pirson, I. (2023). Proximity Interactome Analysis of Super Conserved Receptors Expressed in the Brain Identifies EPB41L2, SLC3A2, and LRBA as Main Partners. Cells, 12(22), 2625. doi:10.3390/cells12222625
  6. 6. Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J.-B., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., Le Stang, N., TABONE-EGLINGER, S., Galateau-Salle, F., Blanquart, C., van Meerbeeck, J. P., Berghmans, T., Jean, D., & Roger, P. P. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular Oncology. doi:https://doi.org/10.1002/1878-0261.13351
  7. 7. Rovira I Berger, M., Miserocchi, M., Montanari, A., Hammou, L., Chomette, L., Pozo Gomez, J., Imbault, V., Bisteau, X., & Wittamer, V. (2022). Zebrafish Galectin 3 binding protein is the target antigen of the microglial 4C4 monoclonal antibody. Developmental dynamics. doi:10.1002/dvdy.549
  8. 8. Redondo Marin, J. A., Bibes, R., Vercauteren Drubbel, A., Dassy, B., Bisteau, X., Maury, E., & Beck, B. (2021). PER2 Circadian Oscillation Sensitizes Esophageal Cancer Cells to Chemotherapy. Biology, 10(4), 266. doi:10.3390/biology10040266
  9. 9. Bisteau, X., Lee, J., Srinivas, V., Lee, J. J., Niska-Blakie, J., Tan, G., Yap, S. Y. X., Hom, K. K., Wong, C. K., Chae, J., Wang, L. C., Kim, J., Rancati, G., Sobota, R. M., Tan, C. C., & Kaldis, P. (2020). The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis. Oncogene. doi:10.1038/s41388-020-01470-1
  10. 10. Dewhurst, M. M., Ow, J. R., Zafer, G., van Hul, N. K. M., Wollmann, H., Bisteau, X., Brough, D., Choi, H., & Kaldis, P. (2020). Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLOS genetics, 16(11), e1009084. doi:10.1371/journal.pgen.1009084
  11. 11. Palmer, N., Talib, Z. S., Ratnacaram, C. K., Low, D., Bisteau, X., Lee, J. H. S., Pfeiffenberger, E., Wollmann, H., Tan, J. H. L., Wee, S., Sobota, R. M., Gunaratne, J., Messerschmidt, D. D., Guccione, E., & Kaldis, P. (2019). CDK2 regulates the NRF1/Ehmt1 axis during meiotic prophase I. The Journal of cell biology, 218(9), 2896-2918. doi:10.1083/jcb.201903125
  12. 12. Szmyd, R., Niska-Blakie, J., Diril, K., Renck Nunes, P., Tzelepis, K., Lacroix, A., van Hul, N. K. M., Deng, L.-W., Matos, J., Dreesen, O., Bisteau, X., & Kaldis, P. (2019). Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality. Oncogene, 38(7), 998-1018. doi:10.1038/s41388-018-0464-0
    13. << Précédent 1 2 3 4 Suivant >>